TD Private Client Wealth’s Halozyme HALO Stock Holding History

TD Private Client Wealth’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.2K	Buy	232 +59	+34%	+$4.02K	﹤0.01%	1049
2026 Q1	$11.2K	Buy	173 +119	+220%	+$8.39K	﹤0.01%	1087
2025 Q4	$3.63K	Buy	54 +2	+4%	+$135	﹤0.01%	1200
2025 Q3	$3.81K	Hold	52	–	–	﹤0.01%	1170
2025 Q2	$2.71K	Sell	52 -24	-32%	-$1.37K	﹤0.01%	1186
2025 Q1	$4.85K	Sell	76 -258	-77%	-$15K	﹤0.01%	1084
2024 Q4	$16K	Buy	334 +296	+779%	+$15.2K	﹤0.01%	1002
2024 Q3	$2.17K	Buy	38 +16	+73%	+$917	﹤0.01%	1175
2024 Q2	$1.15K	Buy	+22	New	+$965	﹤0.01%	1165
2021 Q4	–	Sell	-24	Closed	-$976	–	1206
2021 Q3	$976	Hold	24	–	–	﹤0.01%	1106
2021 Q2	$1.09K	Hold	24	–	–	﹤0.01%	1102
2021 Q1	$1K	Hold	24	–	–	﹤0.01%	1070
2020 Q4	$1.02K	Hold	24	–	–	﹤0.01%	1016
2020 Q3	$631	Hold	24	–	–	﹤0.01%	1008
2020 Q2	$643	Hold	24	–	–	﹤0.01%	1001
2020 Q1	$432	Hold	24	–	–	﹤0.01%	983
2019 Q4	$426	Buy	+24	New	+$416	﹤0.01%	1006

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

TD Private Client Wealth's HALO Position: Q2 2026 in Review

TD Private Client Wealth increased its Halozyme (HALO) stake by 34% in Q2 2026, buying an estimated $4.02K and bringing the position to 232 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

TD Private Client Wealth first reported a position in HALO in Q4 2019 and has held it in 17 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

TD Private Client Wealth held 232 shares of Halozyme worth $18.2K as of Q2 2026.
TD Private Client Wealth bought 59 Halozyme shares in Q2 2026, an estimated $4.02K.
Halozyme made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #1049 holding.
TD Private Client Wealth first reported a position in Halozyme in Q4 2019 and has held it in 17 quarters since.
671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.